"Study Reveals Shocking Discrepancy in Ozempic Manufacturing Costs"

Senator Bernie Sanders is demanding a meeting with Novo Nordisk's CEO to discuss lowering the price of the diabetes and obesity drug Ozempic, which costs nearly $1,000 per month in the US. This comes after a study revealed that the drug could be manufactured for less than $5 per month. Sanders called the current price "outrageous" and is considering hearings on the cost of similar drugs. He also expressed concerns about the impact on Medicare and Medicaid budgets and hopes to lower out-of-pocket costs for patients. The rising costs of these drugs have led to questions about sustainability and coverage by state health plans and Medicaid offices.